Understanding Charcot-Marie-Tooth Disease through patient data
Official title: Global Registry for Inherited Neuropathies Natural History Study for Charcot Marie Tooth Disease
Run by Hereditary Neuropathy Foundation · NCT05902351 · Data updated 2026-11-12
This study is collecting information from people with Charcot-Marie-Tooth Disease to better understand their experiences and help improve future treatments.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | Hereditary Neuropathy Foundation Government |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | November 1, 2013 |
| Main results expected | December 31, 2029 |
| Study ends | December 31, 2029 |
| Registry record updated | September 17, 2026 |
| Trial ID | NCT05902351 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals of all ages with a confirmed or suspected diagnosis of Charcot-Marie-Tooth Disease or other inherited neuropathies.
✕Probably not a fit
Patients who do not have Charcot-Marie-Tooth Disease or other inherited neuropathies will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to gather and analyze patient-reported data, genetic reports, Electronic Health Records (EHRs), and clinical notes related to Charcot-Marie-Tooth Disease (CMT). By documenting the burden and diagnostic journey of individuals with CMT, the study seeks to enhance understanding of the disease's prevalence and characteristics. Participants will complete a Natural History Survey to contribute valuable insights that could inform future research and potential treatments.
Why it matters
Potential benefit: If successful, this study could provide critical data that aids in the development of effective treatments for Charcot-Marie-Tooth Disease.
How similar studies have gone: While this study focuses on natural history, similar observational studies have successfully contributed to understanding other genetic conditions, indicating potential for valuable insights.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients will be made aware of the study by HNF and others (referenced above) and invited to participate. Once patients have reviewed and signed electronically the informed consent document, it is attached to their file. All affected individuals with CMT/IN are eligible to participate in GRIN with proper informed consent. Children, adolescents and adults with either a confirmed diagnosis or suspected to have CMT/IN are eligible with parent and/or guardian consent. Individuals that have been clinically diagnosed through family history and/or standard clinical testing (e.g. neuro exam, EMG, NCS) and/or genetically tested or suspected to have CMT/IN (note: many mutations have not been identified yet) are eligible. Exclusion Criteria: People that do not have Charcot-Marie-Tooth or other Inherited Neuropathies
Where it's running
-
Hereditary Neuropathy Foundation
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Allison Moore — Hereditary Neuropathy Foundation
- Study coordinator: Allison Moore
- Email: allison@hnf-cure.org
- Phone: 212-722-8396
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Tremor in Charcot–Marie–Tooth disease
Try to characterize tremor in adults with Charcot–Marie–Tooth (CMT) disease using surface electromyography, accelerometers, a clinical exam and questionnaires to see how tremor affects daily life.
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
-
Nerve function and structure in CMT, anti‑MAG neuropathy, and CIDP
This project will test nerve‑conduction, axonal‑excitability, skin biopsy, and ultrasound measures in adults with CMT, CIDP, or anti‑MAG neuropathy to see if they better describe nerve function and structure.
-
Portable markerless video system to measure walking in adults with neuromuscular conditions or healthy volunteers.
This project will test a portable video device that measures walking patterns to see if it can track gait changes in adults with neuromuscular diseases and in healthy volunteers.
-
Ankle-foot braces versus surgery to improve walking and balance in CMT
This will test whether ankle-foot braces or surgical correction better improve walking, balance, and mobility for people aged 12 to 75 with genetically confirmed Charcot–Marie–Tooth disease.
-
8-week lower-limb resistance program for young people with Charcot–Marie–Tooth disease
This program will test whether 8 weeks of supervised lower-limb resistance exercises help improve muscle quality, functional ability, and quality of life in 15–29 year olds with and without Charcot–Marie–Tooth disease.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.